In vitro Interactions Between Tumor Cells and Immune Lymphoid Cells

  • J. P. Levy
  • E. Gomard
  • A. Senik
  • J. C. Leclerc
Part of the Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer book series (RECENTCANCER, volume 56)


In the past 6 years after the very important initial contribution of HELLSTRÖM (11), about 100 papers have been published, reporting the existence of tumor-specific, cell-mediated immune reactions (CMIR) in man. Now, in the last 2 years, several groups have clearly demonstrated that most, and perhaps all, of these results are not related to the anti-tumor response, since they also exist in controls at the same level and with the same frequency (3, 5, 20, 29). In fact, no attention has been given to the nature of the effector cell or to their specificity in many of the experiments reported. Perhaps it is useful to return to clear experimental models to try to etablish the significance of the in vitro methods used in investigations on cell-mediated antitumor immunity, and to determine whether the anti-tumor immune response is actually a response against the tumor or in fact an intercurrent phenomenon.


Effector Cell Sarcoma Cell Othe Hand Murine Sarcoma Virus Culture Melanoma Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aoki, T., Stephenson, J.R., Aaronson, S.A., Hau, K.C.: Surface antigens of mammalian sarcoma virus-transformed non producer cells. Proc. Nat. Acad. Sci. USA 71, 3445 (1974)PubMedCrossRefGoogle Scholar
  2. 2.
    Bean, M.A., Pees, M., Rosen, G., Oettgen, H.F.: Prelabeling target cells with 3H-proline as a method for studying lymphocyte cytotoxicity. Nat. Cancer Inst. Monograph 37, 41 (1973)Google Scholar
  3. 3.
    Bloom, E.T., Ossorio, R.C., Brosman, S.A.: Cell-mediated cytotoxicity against human bladder cancer. Int. J. Cancer 14, 32 6 (1974)Google Scholar
  4. 4.
    Chia, E., Festenstein, H.: Specific cytostatic effect of lymph node from normal and T-cell deficient mice on syngeneic tumor target cells in vitro and its specific abrogation by body fluids from syngeneic tumor-bearing mice. Europ. J. Immunol. 3, 483 (1973)CrossRefGoogle Scholar
  5. 5.
    De Vries, J.E., Cornain, S., Rumke, P.: Cytotoxicity of non-T versus T-lymphocytes from melanoma patient and healthy donors on short and long term cultured melanoma cells. Int. J. Cancer 14, 427 (1974)PubMedCrossRefGoogle Scholar
  6. 6.
    Gomard, E., Leclerc, J.C., Levy, J.P.: Spontaneous anti lymphoma reaction of preleukaemic AKR mice: a non-T cell killing. Nature 250, 671 (1974)PubMedCrossRefGoogle Scholar
  7. 7.
    Gomard, E., Henin, Y., Levy, J.P.: Target antigens in the cell mediated anti-tumor in vitro reactions in the MSV system. I. Antigens detected on sarcoma cells by the proline assay. To be published 1976Google Scholar
  8. 8.
    Gorczynski, R.M.: Immunity to murine sarcoma virus induced tumors. I. Specific T lymphocytes active in MMI and lymphocyte transformation. J. Immunol. 112, 1815 (1974)PubMedGoogle Scholar
  9. 9.
    Gorczynski, R.M., Knight, R.A.: Immunity to murine sarcoma virus induced tumours. IV. Direct cellular cytolysis of 51Cr labeled tart cells in vitro and analysis of blocking factors which modulate cytotoxicity. Brit. J. Cancer 31, 387 (1975)PubMedCrossRefGoogle Scholar
  10. 10.
    Halliday, W.J.: Blocking effect of serum from tumor bearing animals on macrophage migration inhibition with tumor antigens. J. Immunol. 106, 855 (1971)PubMedGoogle Scholar
  11. 11.
    Hellström, I., Hellström, K.E.: Studies on cellular immunity and its serum-mediated inhibition in Moloney-virus induced mouse sarcomas. Int. J. Cancer 4, 587 (1969)PubMedCrossRefGoogle Scholar
  12. 12.
    Herberman, R.B., Aoki, T., Nunn, M., Lavrin, D.H., Soares, N., Gazdar, A., Holden, H., Chang, K.S.S.: Specificity of 51Cr release cytotoxicity of lymphocytes immune to murine sarcoma virus. J. Nat. Cancer Inst. 53, 1103 (1974)PubMedGoogle Scholar
  13. 13.
    Herberman, R.B., Nunn, M.E., Holden, H.T., Lavrin, D.H.: Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Int. J. Cancer 16, 230 (1975)PubMedCrossRefGoogle Scholar
  14. 14.
    Kiessling, R., Klein, E., Pross, H., Wigzell, H.: “Natural” killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cells. Europ. J. Immunol. 5, 117 (1975)CrossRefGoogle Scholar
  15. 15.
    Kirchner, H., Muchmore, A.V., Chused, T.M., Holden, H.T., Herberman, R.B.: Imhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleen of tumor bearing mice. J. Immunol. 114, 206 (1975)PubMedGoogle Scholar
  16. 16.
    Lamon, E.W., Skurzak, H.M., Klein, E., Wigzell, H.: In vitro cytotoxicty by a non thymus processed lymphocyte population with specificity for a virally determined tumor cell surface antigen. J. Exp. Med. 136, 1072 (1972)PubMedCrossRefGoogle Scholar
  17. 17.
    Lavrin, D.H., Herberman, R.B., Nunn, M, Soares, N.: In vitro cytotoxicity studies of murine sarcoma virus-induced immunity in mice. J. Nat. Cancer Inst. 51, 1497 (1973)PubMedGoogle Scholar
  18. 18.
    Leclerc, J.C., Gomard, E., Levy, J.P.: Cell-mediated reaction against tumors induced by oncornaviruses. I. Kinetics and specificity of the immune response in murine sarcoma virus (MSV) induced tumors and transplanted lymphomas. Int. J. Cancer 10, 589 (1972)PubMedCrossRefGoogle Scholar
  19. 19.
    Leclerc, J.C., Gomard, E., Plata, F., Levy, J.P.: Cell-mediated immune reaction against tumors induced by oncornaviruses. II. Nature of the effector cells in tumor cell cytolysis. Int. J. Cancer 11, 426 (1973)PubMedCrossRefGoogle Scholar
  20. 20.
    Peter, H., Pavie-Fisher, J., Fridman, W.H.., Aubert, C., Cesarini, C., Roubin, R., Kourilsky, F.M.: Cell-mediated cytotoxicity in vitro of normal human lymphocyte against tissue culture melanoma cell line (IGR 3). J. Immunol. 115, 539 (1975)PubMedGoogle Scholar
  21. 21.
    Plata, F., Gomard, E., Leclerc, J.C., Levy, J.P.: Comparative in vitro studies on effector cell diversity in the cellular immunity to murine sarcoma virus (MSV)-induced tumors in mice. J. Immunol. 112, 1477 (1974)PubMedGoogle Scholar
  22. 22.
    Plata, F., Levy, J.P.: Blocking of syngeneic effector T cells by soluble tumour antigens. Nature 249, 272 (1974)CrossRefGoogle Scholar
  23. 23.
    Plata, F., Cerottini, J.C., Brummer, K.T.: Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system. Europ. J. Immunol. 5, 227 (1975)CrossRefGoogle Scholar
  24. 24.
    Seeger, R.C., Rayner, S.A., Owen, J.J.T.: An analysis of variables affecting the measurement of tumor immunity in vitro with 125I-iodo-deoxyuridine labeled target cells. Studies of immunity to primary Moloney sarcomas. Int. J. Cancer 13, 697 (1974)PubMedCrossRefGoogle Scholar
  25. 25.
    Senik, A., Gomard, E., Plata, F., Levy, J.P.: Cell-mediated immune reaction against tumors induced by oncornaviruses. III. Studies by mixed lymphocyte. Tumor reaction. Int. J. Cancer 12, 233 (1973)PubMedCrossRefGoogle Scholar
  26. 26.
    Senik, A., De Giorgi, L., Levy, J.P.: Cell-mediated anti-tumor immunity in oncornaviruses-induced tumors: specific cytostasis of tumor cells by spleen and lymph node cells. Int. J. Cancer 14, 386 (1974)PubMedCrossRefGoogle Scholar
  27. 27.
    Senik, A., Pozzo-Hebrero, F., Levy, J.P.: Secondary specific immune response in vitro to MSV tumor cells. Int. J. Cancer 16, 946 (1975)PubMedCrossRefGoogle Scholar
  28. 28.
    Senik, A., Gisselbrecht, S., Levy, J.P.: Antigenic specificities of the cell-mediated anti-tumor reactions in the MSV system studied by the secondary chromium release test. Int. J. Cancer 16, 960 (1975)PubMedCrossRefGoogle Scholar
  29. 29.
    Takasugi, M., Mickey, M.R., Terasaki, P.J.: Reactivity of lymphocyte from normal persons on cultured tumor cells. Cancer Res. 33, 2898 (1973)PubMedGoogle Scholar
  30. 30.
    Ting, C.C., Shin, C., Rodrigues, D., Herberman, R.B.: Cell-mediated immunity to Friend virus induced leukemias. Cancer Res. 34, 1684 (1974)PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1976

Authors and Affiliations

  • J. P. Levy
  • E. Gomard
  • A. Senik
  • J. C. Leclerc

There are no affiliations available

Personalised recommendations